Glaxo Still Chasing FDA Approval For Cervarix The FDA’s approval for the ‘other’ HPV-vaccine, Cervarix is still delayed. GlaxoSmithKline, the world's second-largest drugmaker, requested a 'priority' review, potentially prompting an approval decision and sale of the Cervarix … [Read more...] about Glaxo Gearing Up To Compete with Merck’s Gardasil In US Market